Oxford Biomedica (OXB)

Sector:

Pharma and Biotech

Index:

FTSE 250

631.00p
   
  • Change Today:
      14.00p
  • 52 Week High: 682.00p
  • 52 Week Low: 232.50p
  • Currency: UK Pounds
  • Shares Issued: 120.54m
  • Volume: 24,182
  • Market Cap: £760.60m
  • RiskGrade: 125
  • Beta: 1.78

OXB Overview

Oxford Biomedica develops innovative new IP-protected , LentiVector® based therapies, leveraging our internal research expertise and know-how. We select patient-centric product candidates and progress these through proof-of-concept, and into early clinical development, before either seeking third-party funding for full development and commercialisation or to develop further in-house.
Registrars: Capita Registrars

Key Personnel

CEO: Frank Mathias
CFO: Lucinda (Lucy) Crabtree
Chairman: Roch Doliveux
Independent Non-Executive Director: Heather Preston
Independent Non-Executive Director: Namrata P Patel
Senior Independent Director: Dame Kay Davies
Non-Executive Dir: Laurence Espinasse, Colin Bond , Peter Soelkner

Contact Details

Address: Windrush Court, Transport Way, Oxford, United Kingdom, OX4 6LT
Phone: +44 (0) 1865 783 000
Fax: +44 (0) 1865 783 001
Website: http://www.oxb.com/

Listings

Sector: Pharma and Biotech(LSE)
Index: techMARK, FTSE 250, FTSE 350, FTSE All-Share, FTSE techMARK Focus
Overseas Listings: BATSLON:OXBL
ISIN: GB00BDFBVT43

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: RiskGrade figures are provided by RiskMetrics.

 

OXB Market Data

Currency UK Pounds
Share Price 631.00p
Change Today 14.00p
% Change 2.27 %
52 Week High 682.00p
52 Week Low 232.50p
Volume 24,182
Shares Issued 120.54m
Market Cap £760.60m
Beta 1.78
RiskGrade 125

OXB Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
35.16% below the market average35.16% below the market average35.16% below the market average35.16% below the market average35.16% below the market average
17.07% above the sector average17.07% above the sector average17.07% above the sector average17.07% above the sector average17.07% above the sector average
Price Trend
84.11% above the market average84.11% above the market average84.11% above the market average84.11% above the market average84.11% above the market average
86.36% above the sector average86.36% above the sector average86.36% above the sector average86.36% above the sector average86.36% above the sector average
Income Not Available
Growth
5.07% above the market average5.07% above the market average5.07% above the market average5.07% above the market average5.07% above the market average
24.14% below the sector average24.14% below the sector average24.14% below the sector average24.14% below the sector average24.14% below the sector average

What The Brokers Say

Strong Buy 5
Buy 2
Neutral 3
Sell 0
Strong Sell 0
Total 10
buy
Broker recommendations should not be taken as investment advice, and are provided by the authorised brokers listed on this page.

OXB Dividends

No dividends found

Trades for 02-Jan-2026

Time Volume / Share Price
09:12 4 @ 633.00p
09:08 2 @ 632.65p
09:08 78 @ 631.05p
09:05 100 @ 631.00p
09:05 135 @ 631.00p

OXB Key Personnel

Chair Roch Doliveux
CEO Frank Mathias
CFO Lucinda (Lucy) Crabtree

Top of Page